Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Closol is a topical pharmaceutical product brand for **clobetasol propionate**, a superpotent synthetic corticosteroid used for inflammatory and pruritic dermatoses such as psoriasis, eczema, dermatitis, lichen planus, and related allergic or inflammatory skin disorders. It is a **small-molecule steroid** formulated for external use in dosage forms including ointment, cream, lotion, foam, and spray, typically at 0.05% strength. Clobetasol exerts anti-inflammatory, antipruritic, and vasoconstrictive effects primarily through activation of the glucocorticoid receptor, leading to altered gene transcription and induction of phospholipase A2 inhibitory proteins that suppress downstream production of inflammatory mediators including prostaglandins and leukotrienes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Closol.